tiprankstipranks
Salarius Pharmaceuticals Inc (SLRX)
NASDAQ:SLRX
US Market

Salarius Pharmaceuticals (SLRX) Income Statement

Compare
518 Followers

Salarius Pharmaceuticals Income Statement

Last quarter (Q3 2024), Salarius Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Salarius Pharmaceuticals's net income was $-972.12K. See Salarius Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 1.84M$ 5.23M$ 3.47M
Gross Profit
$ -10.05K$ -6.68K$ 1.82M$ 5.23M$ 3.46M
Operating Expenses
$ 12.89K$ 22.98M$ 14.65M$ 12.84M$ 11.73M
Depreciation and Amortization
$ 10.05K$ 6.68K$ 19.18K$ 18.06K$ 16.93K
EBITDA
-$ -31.60M$ -12.75M$ -7.33M$ -6.92M
Operating Income
-$ -31.84M$ -12.81M$ -7.79M$ -9.58M
Other Income/Expenses
-$ 233.18K$ 44.69K$ 434.09K$ 1.33M
Pretax Income
-$ -31.61M$ -12.77M$ -7.35M$ -6.94M
Net Income
-$ -31.37M$ -12.70M$ -7.10M$ -5.61M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.00$ -14.77$ -7.68$ -11.39$ -42.90
Diluted EPS
$ 0.00$ -14.77$ -7.68$ -11.39$ -42.90
Weighted Average Shares Outstanding
3.26M 2.12M 1.65M 623.14K 130.75K
Weighted Average Shares Outstanding (Diluted)
3.26M 2.12M 1.65M 623.14K 130.75K
Currency in USD

Salarius Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis